BioClinica and Theorem Clinical Research have joined The Association of Clinical Research Organizations (ACRO). Dr. John Hubbard, president and chief executive officer of BioClinica will become a member of the ACRO board of directors. Dr. Hubbard has more than 30 years of experience in clinical research and drug development, and previously served as senior vice president and worldwide head of development operations at Pfizer.

BioClinica is a global provider of medical imaging services, eClinical technologies, clinical research centers and cardiovascular safety solutions to support clinical research.   
 
Theorem is joining ACRO as an associate member. Theorem is a global provider of comprehensive clinical services and is focused on analytic-based development, combination trials and personal data applications for the biopharmaceutical, medical device and diagnostics industries.
 
“I am delighted to welcome BioClinica and Theorem to the association and especially look forward to working with Dr. Hubbard on the ACRO Board,” said ACRO chairman Jamie Macdonald, chief executive officer of INC Research. “Our expanding membership is further evidence of the important role ACRO plays in promoting the interests of the CRO industry globally.”
 
Founded in 2002, ACRO represents clinical research organizations (CROs) that provide specialized services for the development of drugs, biologics and medical devices.ACRO and its members advocate on a global basis for safe, ethical, high-quality medical research.